Lang F, Voss A, Kobbe G, Junghanss C, et al. Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemia. Leuk Lymphoma 2025 Feb 8:1-9. doi: 10.1080/10428194.2025.2460737.
PMID: 39921529